This week's hall of fame member is Karl-Erik Andersson.
Name: Karl-Erik Andersson
Profession: Clinical Pharmacologist/ Basic scientist.
Why are you an ICS member: I became a member of the ICS in the 1970-ies because at that time it was a relatively small society where experienced clinical scientists, mainly urologists, met and discussed with younger colleagues, both from the preclinical and clinical fields. Even if the ICS has grown and includes many specialities, it is still a forum that brings together people from preclinical and clinical sciences within the continence/incontinence field in a unique way.
Which was your first ICS meeting: Glasgow, 4th - 6th September 1975
Special ICS memories: I have too many!
Biggest influence: Showing that translational research (going from basic science to bed-side) is an exciting and promising approach to the continence/incontinence field.
The one paper (or book/article/video) you must read/view: Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev. 2004 Dec;56(4):581-63
If you could go back in time what advice would you give to yourself and why: Collaborate with people within other specialties - they may have special skills that you can transfer to your own field of interest. Always try to look for new approaches to the field
Biography: Dr. Karl-Erik Andersson was born and raised in Sweden. He received his medical degree from the University of Lund in 1968, where he subsequently worked as a lecturer in Clinical Pharmacology. He completed his Ph.D. at the Department of Pharmacology, Lund University, in 1973. From 1968 to 1975 he was trained at the Department of Internal Medicine, Lund University Hospital, and in 1975 he obtained a Swedish specialist degree in Internal Medicine 1975 he was appointed as Professor of Clinical Pharmacology at the University of Odense, Denmark. From 1976 to 1978 he had the same position at the University of Aarhus, Denmark. From 1978-2006 he was Professor and Chairman of the Department of Clinical Pharmacology, University of Lund, Lund, Sweden. From 2006 to 2019 he was professor at the Institute for Regenerative Medicine, Wake Forest University, Winston-Salem, North Carolina. He has been visiting professor at the Department of Obstetrics and Gynaecology, University of Toronto (1983-1985), the Department of Urology, University of Virginia, Charlottesville, USA (1997-1998), and Department of Obstetrics and Gynecology, Aarhus University, Denmark (2014-2018. From 1993 to 2000 Dr. Andersson was elected Research Dean of the Medical Faculty at the University of Lund. He is currently Professor Emeritus, Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, NC and Professor Emeritus, Laboratory Medicine, Lund University, Lund, Sweden He is a member of many international societies including the American Urological Association, the European Association of Urology, Society for Urodynamics and Female Urology, and the International Society for Sexual Medicine. He was 2008-2016 Editor of Investigative Urology (Journal of Urology), and he is currently Section Editor of Neurourology and Urodynamics, World Journal of Urology, and Deputy Editor-in-Chief of International Neurourology Journal, and he serves on the Editorial Boards of several other journals. Dr Andersson has been Committee Chairman in the 1st to 6th International Consultations on Incontinence 1998 to 2016 and will be for the 7th in 2020. He has received the Lifetime Career Award of European, Society for Sexual Medicine (ESSM) 2005, Lifetime Achievement Award, Society for Urodynamics and Female Urology (SUFU) 2007, and Lifetime Achievement Award, International Continence Society (ICS) 2014. Andersson's research interests include urogenital and cardiovascular pharmacology and physiology and clinical trials. During his career, Dr. Andersson has authored more than 1000 articles in peer-reviewed international journals.